Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ: WGS )

107.11 +1.42 (+1.34%)
Streaming Delayed Price Updated: 1:56 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about GeneDx Holdings Corp. - Class A Common Stock

< Previous 1 2 3 4 Next >
Exploring high growth characteristics of GENEDX HOLDINGS CORP (NASDAQ:WGS).
UA fundamental and technical analysis of (NASDAQ:WGS): nlocking the high Growth Potential of GENEDX HOLDINGS CORP (NASDAQ:WGS). 
Via Chartmill
GeneDx Eyes Global Genomic Leadership With Fabric Genomics Buyout For Up To $51 Million
GeneDx (NASDAQ: WSG) to acquire Fabric Genomics, pioneer in AI-powered genomic interpretation, for up to $51 million. Expanding global reach and improving precision diagnostics. 
Via Benzinga
IBD 50's GeneDx Inks $84 Million AI-Tied Takeover Deal
GeneDx will pay up to $84 million to acquire Fabric Genomics for its AI-powered genomics interpretation platform. 
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why GENEDX HOLDINGS CORP (NASDAQ:WGS) could fit Mark Minervini’s high-growth criteria
A fundamental and technical analysis of (NASDAQ:WGS): Should you consider GENEDX HOLDINGS CORP (NASDAQ:WGS) for high growth investing? 
Via Chartmill
Unlocking the high Growth Potential of GENEDX HOLDINGS CORP (NASDAQ:WGS).
Exploring high growth characteristics of GENEDX HOLDINGS CORP (NASDAQ:WGS). A fundamental and technical analysis of (NASDAQ:WGS). 
Via Chartmill
Why NASDAQ:WGS qualifies as a high growth stock.
Why the high growth investor may take a look at GENEDX HOLDINGS CORP (NASDAQ:WGS). 
Via Chartmill
Does GENEDX HOLDINGS CORP (NASDAQ:WGS) align with Mark Minervini’s trading strategy?
A fundamental and technical analysis of (NASDAQ:WGS): Why the high growth investor may take a look at GENEDX HOLDINGS CORP (NASDAQ:WGS). 
Via Chartmill
SPY Trying To Find A Floor At The 200 SMA; One New Swing
In this video lesson I review the day-one of a new rally attempt in the overall market, discuss my new swing trade in a cyber-security leader, and review my tier-one long-term portfolio purchases in my... 
Via Talk Markets
Topics Stocks / Equities
Powerful UnR Session As All Four Market Indices Lockstep Rally Into The Close; Bear Trap Set?
In this video lesson, I review the overall market, the recent bearish sentiment, and one new swing trade idea for Monday's session. 
Via Talk Markets
Topics Stocks / Equities
Top Biotech GeneDx Catapults 42% After Obliterating Earnings Forecasts
GeneDx stock catapulted more than 40% on Tuesday after the top-notch biotech smashed fourth-quarter expectations. 
Via Investor's Business Daily
Crude Oil Gains 1.5%; Fluor Shares Plunge Following Downbeat Earnings
Via Benzinga
Exposures Fossil Fuels
Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
US, Russia Begin Ukrainian Peace Talks, Intel Shares Surge: What's Driving Markets Tuesday?
Major U.S. indices are little-changed in Tuesday's midday trading as investors monitor recent geopolitical developments and anticipate the release of the latest FOMC minutes on Wednesday. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
Top performing mid-cap stocks last week: WRD (+97.62%), GDS (+43.45%), SWTX (+42.58%), RXRX (+40.59%), SOC (+39.09%), WGS (+28.23%), VNET (+28.22%), NSP (+25.99%), CRSP (+25.21%), AXSM (+24.01%) 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Earnings Scheduled For February 18, 2025
Via Benzinga
GeneDx: Even After Up 2,700% in 2024, Upside Is Still in Play
Saying shares of GeneDx skyrocketed in 2024 may be an understatement. As a leader in its market, upside is still a legitimate possibility for this name. 
Via MarketBeat
Stocks Moving Lower Despite Encouraging Inflation Data
Via Talk Markets
Topics Economy Stocks / Equities
Exposures Interest Rates
I’m Not Worried About This Pullback
Stocks gave back all of Monday’s gains and then some today. Monday’s panic buyers were mercilessly punished for going nuts during the spree. 
Via Talk Markets
Topics Cryptocurrencies Stocks / Equities
IBD 50's GeneDx Surges On FDA Recommendations For AI Device Development
GeneDx provides whole and exome gene sequencing to identify rare diseases. 
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Focus On High Cash Flow Companies. You Are The Company You Keep.
There are too many stocks acting well to expect a bear market right now. 
Via Talk Markets
Topics Stocks / Equities
Meta Stock, Energy Plays Lead Five Leaders Rebounding Bullishly
Energy plays, a biotech and a brokerage also are flashing buy signals or setting up. 
Via Investor's Business Daily
Resources Connection, SPS Commerce And 3 Stocks To Watch Heading Into Friday
US stock futures up, GeneDx appoints new COO, Lifecore beats expectations, SPS Commerce acquires Carbon6, Resources Connection & UDR report strong quarters. 
Via Benzinga
Best Performing Stocks Of 2024
A look at the some of best performing stocks in 2024 of current Russell 3,000 members. 
Via Talk Markets
Topics Stocks / Equities
The Top 5 Mid Cap Stocks Of 2024
These high-fliers are on the leading edge of innovation. 
Via Talk Markets
Topics Stocks / Equities
Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year
Via The Motley Fool
Don’t Confuse Brains With A Bull Market, Or Price With Value
If you are interested in the stock market, maybe it is time to stop focusing on The Fed. 
Via Talk Markets
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
Top mid-cap stock performers: MDGL (+51.70%), PRCT (+34.20%), GSAT (+33.98%), WGS (+31.17%), NXT (+25.91%), VFC (+25.82%), OMCL (+23.22%). 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.